Oracle's Record AI Backlog Clashes with Negative Cash Flow

What happened

Oracle's AI backlog has surged to $664 billion in remaining performance obligations, prompting some analysts to argue the stock could nearly double. However, the company posted negative free cash flow of $23.7 billion in FY2026 and another $5.4 billion negative in the first quarter of FY2027. CFO Hilary Maxson has not provided a timeline for when free cash flow will turn positive, compounding investor anxiety. The buildout is being funded through $19.9 billion in equity issuance, $25 billion in bonds, and $11.4 billion in customer prepayments, while off-balance-sheet lease commitments have reached $288 billion. With only 13% of RPO expected to convert to revenue in the next 12 months, the market is left questioning whether the balance sheet can bridge the gap until the backlog ramps.

Implication

Near-term, Oracle's negative free cash flow and downgrade risk make the stock vulnerable to further downside; we maintain a WAIT rating with attractive entry around $115. If the next quarterly filings show an increase in the 12-month RPO conversion rate above 13% and customer prepayments remain material, the bull case strengthens. Conversely, any further credit downgrade below BBB- or additional project delays would push the stock toward the bear scenario value of $95. Given the crowded narrative and high balance sheet leverage, position sizing should be small until the company demonstrates that the AI buildout can be funded without further dilution or ratings pressure. We will reassess in 3-6 months as new data emerges.

Thesis delta

The news article does not introduce new facts but reinforces the core tension in our thesis: the gap between a record AI backlog and a strained balance sheet. Our WAIT rating remains intact, as we already flagged negative free cash flow and slow RPO conversion as key risks. No change to our price targets or conviction level at this time.